Analyst Recommendations
35.27 0.29(0.83%)07/03/2024
Apellis Pharmaceuticals Inc (APLS)
Apellis Pharmaceuticals Inc (APLS)
2024: Total Recommendations Consensus
To Grade | # of Recommendations |
---|---|
Buy | 15 |
Neutral | 6 |
Outperform | 4 |
Equal-Weight | 1 |
Overweight | 1 |
Strong Buy | 1 |
5 records were shown. To view all data, Upgrade to PRO plan with only $1
Upgrades & Downgrades